500 results on '"Tse, Yee Kit"'
Search Results
2. Long-term use of tenofovir disoproxil fumarate increases fracture risk in elderly patients with chronic hepatitis B
3. A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial
4. Diabetes Mellitus Impacts on the Performance of Hepatocellular Carcinoma Risk Scores in Chronic Hepatitis B Patients
5. Baveno VII criteria for recompensation predict transplant-free survival in patients with hepatitis B-related decompensated cirrhosis
6. Drug–drug interactions between direct-acting antivirals and co-medications: a territory-wide cohort study
7. Risk of hepatic decompensation but not hepatocellular carcinoma decreases over time in patients with hepatitis B surface antigen loss
8. Scheduled second look endoscopy after endoscopic hemostasis to patients with high risk bleeding peptic ulcers: a Randomized Controlled Trial
9. Dynamic Changes in ELF Score Predict Hepatocellular Carcinoma in Chronic Hepatitis B Patients Receiving Antiviral Treatment.
10. Novel machine learning models outperform risk scores in predicting hepatocellular carcinoma in patients with chronic viral hepatitis
11. Two vs One Forward View Examination of Right Colon on Adenoma Detection: An International Multicenter Randomized Trial
12. FRI-387 Similarly low risk of hepatocellular carcinoma and cirrhotic complications in patients in the HBeAg-negative indeterminate phase compared with chronic infection
13. WED-198 Novel deep learning models utilising domain adaptation outperform conventional statistical models for predicting the risk of liver-related complications in patients with metabolic dysfunction-associated steatotic liver disease
14. Temporal Matrix Completion with Locally Linear Latent Factors for Medical Applications
15. Hepatic Decompensation in Cirrhotic Patients Receiving Antiviral Therapy for Chronic Hepatitis B
16. Negligible HCC risk during stringently defined untreated immune-tolerant phase of chronic hepatitis B
17. Fatty Pancreas Is Independently Associated With Subsequent Diabetes Mellitus Development: A 10-Year Prospective Cohort Study
18. Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC
19. Temporal matrix completion with locally linear latent factors for medical applications
20. Risk of hepatitis B surface antigen seroreversion after corticosteroid treatment in patients with previous hepatitis B virus exposure
21. Serum hepatitis B core-related antigen predicts hepatocellular carcinoma in hepatitis B e antigen-negative patients
22. HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues
23. Risk of Postpolypectomy Bleeding With Uninterrupted Clopidogrel Therapy in an Industry-Independent, Double-Blind, Randomized Trial
24. Long-term use of tenofovir disoproxil fumarate increases fracture risk in elderly patients with chronic hepatitis B
25. Normal on-treatment ALT during antiviral treatment is associated with a lower risk of hepatic events in patients with chronic hepatitis B
26. Misoprostol Heals Small Bowel Ulcers in Aspirin Users With Small Bowel Bleeding
27. Effects of Diabetes and Glycemic Control on Risk of Hepatocellular Carcinoma After Seroclearance of Hepatitis B Surface Antigen
28. Electroacupuncture-reduced sedative and analgesic requirements for diagnostic EUS: a prospective, randomized, double-blinded, sham-controlled study
29. Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial
30. High incidence of hepatocellular carcinoma and cirrhotic complications in patients with psychiatric illness: a territory-wide cohort study
31. On-Treatment Improvement of MELD Score Reduces Death and Hepatic Events in Patients With Hepatitis B-Related Cirrhosis
32. Similarly low risk of chronic kidney disease (CKD) progression in chronic hepatitis B patients with Stage 2 CKD on tenofovir alafenamide versus entecavir
33. Secular trends of newly diagnosed chronic hepatitis B in 2000–2022-a territory-wide study
34. IDDF2023-ABS-0051 Laboratory parameter-based model for predicting hepatic complications in non-alcoholic fatty liver disease: a territory-wide cohort study
35. HBsAg seroclearance decreases risk of hepatocellular carcinoma but not hepatic decompensation in nucleos (t)ide analogue-treated cirrhotic patients with complete hepatitis B virus suppression: a territory-wide cohort study
36. Switching to peginterferon for chronic hepatitis B patients with hepatitis B e antigen seroconversion on entecavir-a long term follow-up study
37. Baveno VII criteria identify varices needing treatment in patients with hepatocellular carcinoma of different Barcelona Clinic Liver Cancer stages
38. Duration of type 2 diabetes and liver-related events in nonalcoholic fatty liver disease: A landmark analysis
39. Clinical Outcomes Following Treatment for COVID-19 With Nirmatrelvir/Ritonavir and Molnupiravir Among Patients Living in Nursing Homes
40. Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infection.
41. Trends in risk factor control and treatment among patients with non‐alcoholic fatty liver disease and type 2 diabetes between 2000 and 2020: A territory‐wide study
42. Diabetes mellitus impacts on the performance of hepatocellular carcinoma risk scores in chronic hepatitis B patients
43. Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis
44. A Sequential Machine Learning Model for Identifying At-risk NASH by Combining Liver Stiffness Measurement and Protein Biomarkers
45. Impact of the Use of Oral Antiviral Agents on the Risk of Hospitalization in Community Coronavirus Disease 2019 Patients (COVID-19)
46. IDDF2022-ABS-0226 Long-term risk of hepatocellular carcinoma and hepatic decompensation after hepatitis B surface antigen seroclearance: a territory-wide cohort of 9,769 patients
47. Fatty Pancreas Is Independently Associated With Subsequent Diabetes Mellitus Development: A 10-Year Prospective Cohort Study
48. Universal HBV vaccination dramatically reduces the prevalence of HBV infection and incidence of hepatocellular carcinoma
49. Age and the relative importance of liver‐related deaths in nonalcoholic fatty liver disease
50. Three COVID-19 medications-remdesivir, molnupiravir and ritonavir-boosted nirmatrelvir-and serial liver biochemistries in 22, 456 subjects
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.